Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Veterinary Immunology and Immunopathology|September 19, 2025
GM-CSF-adjuvanted Newcastle disease virus-vectored bivalent vaccine elicits enhanced dual immunity against Newcastle disease and infectious bursal disease in chickensQing Wu, Jinmiao Liu, Weiyue Cao, et al.
International Immunopharmacology|May 28, 2023
Development and evaluation of Newcastle disease - avian influenza bivalent vector vaccines in commercial chickensQing Wu, Lan Wei, Xin Du, et al.
Virulence|August 5, 2024
Evaluation of the immune responses of biological adjuvant bivalent vaccine with three different insertion modes for ND and IBDWenying Sun, Shuang Li, Dun Niu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 21, 2025
Synergistic effect of canine FGF-21 combined with insulin in the treatment of canine diabetesWenying Sun, Yaoqun Wang, Ziran Liu, et al.
Transboundary and Emerging Diseases|January 6, 2021
Development and evaluation of a recombinant VP2 neutralizing epitope antigen vaccine candidate for infectious bursal disease virusXiaochen Guo, Wenying Sun, Lan Wei, et al.
International Immunopharmacology|March 20, 2024
Fibroblast growth factor 21 mitigates lupus nephritis progression via the FGF21/Irgm 1/NLRP3 inflammasome pathwayYimeng Zou, Dan Wang, Wenying Sun, et al.
Gene Therapy|May 16, 2020
Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic virusesTianyan Liu, Yu Zhang, Yukai Cao, et al.
Transboundary and Emerging Diseases|April 5, 2020
The immune enhancement effects of recombinant NDV expressing chicken granulocyte-macrophage colony-stimulating factor on the different avian influenza vaccine subtypesXiaochen Guo, Teng Zhang, Xiangxiang Wang, et al.
International Immunopharmacology|June 1, 2024
Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sproutingQing Wu, Yuhan Jin, Shuang Li, et al.
Pediatric Neurology|December 28, 2022
Safety and Tolerability of COVID-19 Vaccine in Children With Epilepsy: A Prospective, Multicenter StudyZhihao Wang, Xiqin Fang, Tao Han, et al.
Pageof 6